Sulfhydryl Sulfobetaine Stabilized Palladium Nanoparticles with High Peroxidase-like Activity for Enhanced Glutathione Detection and Tumor Suppression.

Ruyu Li, Yanshuai Cui, Shukai Li, Xianbing Ji, Longgang Wang

Abstract read

In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruyu LiHebei Key Laboratory of Nano-Biotechnology, Hebei Key Laboratory of Applied Chemistry, College of Environmental and Chemical Engineering, Yanshan University, Qinhuangdao 066004, China.

Yanshuai CuiHebei Key Laboratory of Agroecological Safety, Department of Environmental Engineering, Hebei University of Environmental Engineering, Qinhuangdao 066102, China.

Shukai LiCollege of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin 150001, China.

Xianbing JiHebei Key Laboratory of Agroecological Safety, Department of Environmental Engineering, Hebei University of Environmental Engineering, Qinhuangdao 066102, China.

Longgang WangHebei Key Laboratory of Nano-Biotechnology, Hebei Key Laboratory of Applied Chemistry, College of Environmental and Chemical Engineering, Yanshan University, Qinhuangdao 066004, China.

Funding

Hebei Provincial Department of Education QN2022124

6 · The paper itself

Abstract

Glutathione (GSH)-responsive nanozymes have attracted increasing attention for biosensing and cancer therapy. However, their practical applications are often limited by aggregation and insufficient catalytic activity. Herein, we report a zwitterionic sulfobetaine-modified palladium nanozyme (SH-SB/Pd NPs) that addresses these limitations by integrating high catalytic activity. The zwitterionic ligand simultaneously stabilizes Pd nanoparticles and preserves accessible catalytic sites, resulting in markedly enhanced peroxidase-like activity. SH-SB/Pd NPs efficiently catalyze H

Indexed as

Antineoplastic AgentsBetaineGlutathioneMetal NanoparticlesPalladiumSulfhydryl CompoundsCatalysisHeLa CellsHumansHydrogen PeroxideAntineoplastic AgentsBetaineGlutathioneHydrogen PeroxidePalladiumSulfhydryl Compoundssulfobetainedetectionglutathionepalladiumphotothermal therapysulfhydryl sulfobetaine

Identifiers

PMID42509797

DOI10.3390/biom16071003

PMCPMC13406491

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.